IMMUNOSUPPRESSIVE AGENTS

You have access
Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody–associated Vasculitis-related Bronchiectasis: Data from 61 Patients
Raphael Lhote, Marie Chilles, Matthieu Groh, Xavier Puéchal, Philippe Guilpain, Félix Ackermann, Zahir Amoura, Isabella Annesi-Maesano, Thomas Barba, Emilie Catherinot, Fleur Cohen-Aubart, Pascal Cohen, Vincent Cottin, Louis-Jean Couderc, Hubert De Boysson, Xavier Delbrel, Stéphane Dominique, Pierre Duhaut, Olivier Fain, Eric Hachulla, Mohamed Hamidou, Jean-Emmanuel Kahn, Christophe Legendre, Alain Le Quellec, François Lhote, François Lifermann, Alexis Mathian, Antoine Néel, Hilario Nunes, Jean-François Subra, Benjamin Terrier, Luc Mouthon, Elisabeth Diot, Loïc Guillevin, Pierre-Yves Brillet and Colas Tcherakian for the French Vasculitis Study Group (FVSG) and the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P)

The Journal of Rheumatology October 1 2020, 47 (10) 1522-1531; DOI: https://doi.org/10.3899/jrheum.190313
You have access
Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study
Akinori Hara, Takashi Wada, Ken-ei Sada, Koichi Amano, Hiroaki Dobashi, Masayoshi Harigai, Yoshinari Takasaki, Hidehiro Yamada, Hitoshi Hasegawa, Taichi Hayashi, Shouichi Fujimoto, Eri Muso, Tamihiro Kawakami, Sakae Homma, Masaharu Yoshida, Junichi Hirahashi, Noriyoshi Ogawa, Satoshi Ito, Hirofumi Makino and Yoshihiro Arimura for the Research Committee on Intractable Vasculitides, and the Strategic Study Group to Establish the Evidence for Intractable Vasculitis Guideline

The Journal of Rheumatology April 1 2018, 45 (4) 521-528; DOI: https://doi.org/10.3899/jrheum.170508
You have access
Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
Simon Yu Tian, Brian M. Feldman, Joseph Beyene, Patrick E. Brown, Elizabeth M. Uleryk and Earl D. Silverman

The Journal of Rheumatology August 1 2015, 42 (8) 1392-1400; DOI: https://doi.org/10.3899/jrheum.141650
You have access
Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study
Hayato Yamazaki, Ryoko Sakai, Ryuji Koike, Yasunari Miyazaki, Michi Tanaka, Toshihiro Nanki, Kaori Watanabe, Shinsuke Yasuda, Takashi Kurita, Yuko Kaneko, Yoshiya Tanaka, Yasuhiko Nishioka, Yoshinari Takasaki, Kenji Nagasaka, Hayato Nagasawa, Shigeto Tohma, Makoto Dohi, Takahiko Sugihara, Haruhito Sugiyama, Yasushi Kawaguchi, Naohiko Inase, Sae Ochi, Hiroyuki Hagiyama, Hitoshi Kohsaka, Nobuyuki Miyasaka and Masayoshi Harigai for the PREVENT Study Group

The Journal of Rheumatology April 1 2015, 42 (4) 614-622; DOI: https://doi.org/10.3899/jrheum.140778
You have access
Immunosuppressive Therapies for the Induction Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
Simon Yu Tian, Brian M. Feldman, Joseph Beyene, Patrick E. Brown, Elizabeth M. Uleryk and Earl D. Silverman

The Journal of Rheumatology October 1 2014, 41 (10) 1998-2007; DOI: https://doi.org/10.3899/jrheum.140050

Main menu

User menu

Search

IMMUNOSUPPRESSIVE AGENTS

Content

Resources

Subscribers

More